对照组不吸入糖皮质激素。
目的探讨吸入糖皮质激素对高危哮喘儿预后的影响。
Objective To explore the effect of inhaling glucocorticoid on the prognosis of high risk asthmatic children.
背景：吸入糖皮质激素治疗在哮喘治疗中具有重要作用。
Background: Inhaled corticosteroid has played an important role in the management of asthma.
中度持续性哮喘的人不能很好地控制低剂量吸入糖皮质激素。
People with moderate persistent asthma are not well controlled on low doses of inhaled corticosteroids.
随机试验一次与吸入糖皮质激素治疗的哮喘儿童每日维兰特罗。
Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.
目的探讨吸入糖皮质激素预防毛细支气管炎反复喘息发作的疗效。
Objective To study the efficacy of inhaling glucocorticoid in preventing bronchiolitis from repeated wheeze outbreak.
纳入者允许同时使用吸入糖皮质激素，前提是这不是随机化治疗的组成部分。
Participants were permitted concomitant use of inhaled corticosteroids, provided this was not part of the randomized treatment regimen.
目的研究吸入糖皮质激素对感染后咳嗽的治疗效果及对气道炎症细胞的影响。
Objective to investigate effect of inhaled corticosteroids on postinfectious cough and the change of inflammatory cells in airway.
前言： 目的：探讨长期吸入糖皮质激素在慢性阻塞肺疾病中的疗效及副作用。
Objective:To investigate the effect and the side effect of Inhaled corticosteroids in chronic obstructive pulmonary disease.
吸入糖皮质激素有可能经肺吸收(入血)，从而有一定程度的全身生物利用度。
Inhaled glucocorticosteroids are absorbed from the lung, accounting for some degree of systemic bioavailability.
结果：长期吸入糖皮质激素治疗慢性阻塞性肺疾病的疗效目前仍未得出一致的结论。
Results: at the present day, there yet is not any agreement on the curative effect of inhaled corticosteroids for a long time to treat chronic obstructive pulmonary disease.
摘要：目的研究性别对肥胖哮喘患儿吸入糖皮质激素(ICS)治疗前后肺功能的影响。
Abstract: Objective To study the association between gender and lung function in obese asthmatic children before and after inhaling corticosteroids (ICS).
以前研究表明吸入糖皮质激素减少炎症反应标记物(如c反应蛋白)和降低气道炎症反应。
Previous studies have shown inhaled corticosteroids reduce markers of inflammation such as C-reactive protein and reduce airway inflammation.
吸入糖皮质激素的口腔沉积率约为80 ~ 90 %，是引发局部和全身副作用的主要原因。
Oral deposition rate of aspiration corticosteroid is 80 ~ 90%. The deposition is the main cause of local and total body side effects.
结论：本研究进一步证实，当考虑到先天畸形的可能性时，孕期吸入糖皮质激素治疗哮喘的安全性。
Conclusion: This study adds evidence to the safety of ICSs for the treatment of asthma during pregnancy, with regard to the likelihood of congenital malformation.
目的探讨支气管哮喘患儿急性发作期口咽部菌群的分布特点及长期吸入糖皮质激素后对其产生的影响。
Objective: To explore the effects of inhaled corticosteroids on distribution of throat flora in children with bronchial asthma.
纳入标准是吸入糖皮质激素与COPD对照相比较的随机对照试验，持续24周或者更长，肺炎是治疗引起的副作用。
Inclusion criteria were randomized controlled trials comparing any inhaled corticosteroid vs a control treatment of COPD, follow-up 24 weeks or longer, and reporting of pneumonia as an adverse event.
他们说，如果更大规模的研究证实这些结果，高剂量吸入糖皮质激素降低COPD人群发生肺癌的风险中具有潜在作用。
If further larger studies confirm these results, they say high doses of inhaled corticosteroids may play a potential role in reducing the risk of lung cancer among people with COPD.
对不吸入糖皮质激素的患者来说，规律使用沙美特罗与规律使用沙丁胺醇相比，其致死性及非致死性严重不良事件的发生率并无显著增加。
Compared with regular salbutamol, regular salmeterol was not associated with a significant increase in fatal or nonfatal serious adverse events in patients not taking inhaled corticosteroids.
目的探讨糖皮质激素吸入疗法对哮喘患儿骨代谢、骨密度和肾上腺功能的影响。
ObjectiveTo explore the effect of glucocorticoid inhaled on bone metabolism, bone density and adrenal function in children with asthma.
目的研究短期吸入小剂量糖皮质激素对哮喘儿童骨转换指标的影响。
Objective To study the effect of short-term inhalation of glucocorticoids on bone turnover markers.
目的：研究吸入性糖皮质激素对豚鼠速发性支气管哮喘的快速作用。
Objective: To explore the rapid effect of inhaled glucocorticoids (GCs) on immediate asthma reaction in guinea pigs.
结论糖皮质激素吸入治疗可减轻COPD的临床症状，改善肺功能，从而提高生活质量。
Conclusion Glucocorticoid treating COPD by inhaling can relieve the clinical symptom of the COPD and improve the lung functions and raise the life quality.
一种超细吸入型糖皮质激素药物粉体的制备方法属于药物微粉化领域。
The preparation process of superfine inhaled glucocorticoid medicine powder belongs to the field of medicine micronizing technology.
一种超细吸入型糖皮质激素药物粉体的制备方法属于药物微粉化领域。
The preparation process of superfine inhaled glucocorticoid medicine powder belongs to the field of medicine micronizing technology.
应用推荐